Original Research

Published on 28 Mar 2023

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Zhongqiang Qin
Bo Xie
Jingyu Qian
Xiang Ma
Lan Zhang
Jianzhu Wei
Zhaoying Wang
Longfei Fan
Ziyi Zhu
Zhen Qian

Frontiers in Oncology

doi 10.3389/fonc.2023.1144269

2,804 views
5 citations

Review

Published on 28 Mar 2023

Long noncoding RNA SNHG15: A promising target in human cancers

in Cancer Molecular Targets and Therapeutics

Niu Zhang
Tianyao Lei
Tianwei Xu
Xiaoteng Zou
Zhaoxia Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1108564

1,939 views
3 citations

Systematic Review

Published on 27 Mar 2023

Acupuncture therapies for cancer-related fatigue: A Bayesian network meta-analysis and systematic review

in Cancer Molecular Targets and Therapeutics

Hao Tian
Yunhui Chen
Mingsheng Sun
Liuyang Huang
Guixing Xu
Chunyang Yang
Qin Luo
Ling Zhao
Zheng Wei
Fanrong Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1071326

4,088 views
4 citations

Original Research

Published on 27 Mar 2023

Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas

in Cancer Molecular Targets and Therapeutics

Ganghua Zhang
Panpan Tai
Jianing Fang
Aiyan Chen
Xinyu Chen
Ke Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1157115

2,205 views
2 citations

Review

Published on 27 Mar 2023

MACC1-induced migration in tumors: Current state and perspective

in Cancer Molecular Targets and Therapeutics

Tim Hohmann
Urszula Hohmann
Faramarz Dehghani

Frontiers in Oncology

doi 10.3389/fonc.2023.1165676

1,833 views
5 citations

Original Research

Published on 24 Mar 2023

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4

in Cancer Molecular Targets and Therapeutics

Jiayu Li
Xuhui Yuan
Cong Ma
Junhong Li
Gaoyang Qu
Bo Yu
Feng Cai
Yuanxiang Peng
Lang Liu
Duo Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1139588

1,841 views
2 citations

Review

Published on 24 Mar 2023

Application status and future prospects of the PDX model in lung cancer

in Cancer Molecular Targets and Therapeutics

Wei Liu
Yishuang Cui
Xuan Zheng
Kunpeng Yu
Guogui Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1098581

3,554 views
6 citations

Brief Research Report

Published on 23 Mar 2023

B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model

in Cancer Molecular Targets and Therapeutics

Jorge R. Galán-Ortíz
Kamila A. Andino del Valle
Abelardo A. Pérez-Rosario
Daniel L. Castañón Pereira
Jennifer Díaz-Rivera
Pamela A. Merheb-Finianos
Stephanie M. Dorta-Estremera

Frontiers in Oncology

doi 10.3389/fonc.2023.1145724

1,990 views
1 citation

Case Report

Published on 23 Mar 2023

Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion

in Cancer Molecular Targets and Therapeutics

Ting Zhao
Xiaowei Zhang
Xin Liu
Min Ren
Yufan Cheng
Jian Wang
Zhiguo Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1147974

2,147 views
2 citations

Editorial

Published on 22 Mar 2023

Editorial: Pulsed electric field based technologies for oncology applications

in Cancer Molecular Targets and Therapeutics

Siqi Guo
Gregor Sersa
Richard Heller

Frontiers in Oncology

doi 10.3389/fonc.2023.1183900

2,661 views
5 citations

Case Report

Published on 22 Mar 2023

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib

in Cancer Molecular Targets and Therapeutics

Mengmeng Li
Ruyue Xing
Jiuyan Huang
Chao Shi
Chunhua Wei
Huijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1084456

2,703 views
7 citations

Review

Published on 21 Mar 2023

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

in Cancer Molecular Targets and Therapeutics

Junwei Yang
Kuansong Wang
Zhichun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1133832

15,444 views
26 citations

Mini Review

Published on 17 Mar 2023

In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders

in Cancer Molecular Targets and Therapeutics

David O. Kamson
Viveka Chinnasamy
Stuart A. Grossman
Chetan Bettegowda
Peter B. Barker
Peter W. Stacpoole
Georg Oeltzschner

Frontiers in Oncology

doi 10.3389/fonc.2023.1077461

2,842 views
5 citations

Original Research

Published on 14 Mar 2023

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Cristina Di Giorgio
Rachele Bellini
Antonio Lupia
Carmen Massa
Martina Bordoni
Silvia Marchianò
Rosalinda Rosselli
Valentina Sepe
Pasquale Rapacciuolo
Federica Moraca

Frontiers in Oncology

doi 10.3389/fonc.2023.1140730

4,219 views
10 citations

Original Research

Published on 13 Mar 2023

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer

in Cancer Molecular Targets and Therapeutics

Lei Chen
Yiyi Ji
Ang Li
Bo Liu
Kai Shen
Ruopeng Su
Zehua Ma
Weiwei Zhang
Qi Wang
Yinjie Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1085569

3,051 views
2 citations

Original Research

Published on 10 Mar 2023

Loss of liver kinase B1 in human seminoma

in Cancer Molecular Targets and Therapeutics

Manish Kumar
Subhransu S. Sahoo
M. Fairuz B. Jamaluddin
Pradeep S. Tanwar

Frontiers in Oncology

doi 10.3389/fonc.2023.1081110

1,067 views

Navigation group

Articles

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

Long noncoding RNA SNHG15: A promising target in human cancers

Acupuncture therapies for cancer-related fatigue: A Bayesian network meta-analysis and systematic review

Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas

MACC1-induced migration in tumors: Current state and perspective

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4

Application status and future prospects of the PDX model in lung cancer

B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model

Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion

Editorial: Pulsed electric field based technologies for oncology applications

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer

Loss of liver kinase B1 in human seminoma